Author

Rafael Bargiela

Consejo Superior de Investigaciones CientíficasORCID 0000-0003-1442-3269Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metagenomics· 1

Frequent Co-Authors

Abraham Esteve‐NúñeziD· 1 shared Francesca Demaria· 1 shared Manuel FerreriD· 1 shared Marcel SuleimaniD· 1 shared Owen L. PetcheyiD· 1 shared Philippe F.-X. CorviniiD· 1 shared Pilar JunieriD· 1 shared Silvia Blázquez HernándeziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abraham Esteve‐NúñezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologyJournal of Hazardous MaterialsPeer-reviewedMar 16, 2026

Micropollutant-driven bacterial adaptation enables resilient pharmaceuticals biodegradation at trace concentrations in biologically treated wastewater.

Francesca Demaria, Marcel Suleiman, Rafael Bargiela…·Pilar Junier

The paper shows that microbial consortia adapted to pharmaceuticals retain degradation capacity across wide concentration ranges and can be applied to real wastewater treatment.

DOI 10.1016/j.jhazmat.2026.141801

metagenomicsexperimental assay

𝕏 PostBluesky